KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Common Equity (2016 - 2025)

Johnson & Johnson's Common Equity history spans 17 years, with the latest figure at $81.5 billion for Q4 2025.

  • For Q4 2025, Common Equity rose 14.06% year-over-year to $81.5 billion; the TTM value through Dec 2025 reached $81.5 billion, up 14.06%, while the annual FY2025 figure was $81.5 billion, 14.06% up from the prior year.
  • Common Equity for Q4 2025 was $81.5 billion at Johnson & Johnson, up from $78.5 billion in the prior quarter.
  • Across five years, Common Equity topped out at $81.5 billion in Q4 2025 and bottomed at $63.3 billion in Q1 2021.
  • The 5-year median for Common Equity is $71.5 billion (2024), against an average of $72.7 billion.
  • The largest annual shift saw Common Equity grew 16.98% in 2022 before it fell 10.46% in 2023.
  • A 5-year view of Common Equity shows it stood at $70.3 billion in 2021, then rose by 6.16% to $74.6 billion in 2022, then dropped by 7.81% to $68.8 billion in 2023, then rose by 3.95% to $71.5 billion in 2024, then rose by 14.06% to $81.5 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Common Equity are $81.5 billion (Q4 2025), $78.5 billion (Q2 2025), and $78.1 billion (Q1 2025).